Clinical Trials in Cardiology

Clinical Trials in Cardiology PDF Author: Bertram Pitt
Publisher: Bailliere Tindall Limited
ISBN:
Category : Medical
Languages : en
Pages : 408

Get Book Here

Book Description
This text, aimed at the clinical cardiologist, covers the planning of and partcipation in a clinical trial. It interprets the importance of past clinical trials in current clinical practice.

Clinical Trials in Cardiology

Clinical Trials in Cardiology PDF Author: Bertram Pitt
Publisher: Bailliere Tindall Limited
ISBN:
Category : Medical
Languages : en
Pages : 408

Get Book Here

Book Description
This text, aimed at the clinical cardiologist, covers the planning of and partcipation in a clinical trial. It interprets the importance of past clinical trials in current clinical practice.

Cardiovascular Clinical Trials

Cardiovascular Clinical Trials PDF Author: Marcus Flather
Publisher: John Wiley & Sons
ISBN: 1405162155
Category : Medical
Languages : en
Pages : 421

Get Book Here

Book Description
The pace of therapeutic advances in the treatment of cardiovascular diseases is rapid, and new clinically-relevant information appears with such frequency that it can be extremely challenging for clinicians to keep up. Still, knowledge and interpretation of major clinical trials is crucial for the range of clinicians who manage cardiovascular patients, especially since important trial evidence often needs to be implemented soon after it is published. Confidently apply gold standard treatment for 10 of the most critical areas of cardiology Written by an international team of experts, Cardiovascular Clinical Trials: Putting the Evidence into Practice: Provides a succinct overview of recent major clinical trials - the gold standard for all medical treatment - across all the major cardiovascular subspecialties, to ensure you’re up-to-date on the most critical findings Guides cardiology trainees and clinicians on how cardiovascular clinical trials are designed and conducted, including statistical methodology, so you can conduct and/or appraise future trials yourself Addresses methodology as well as clinical effectiveness Offers evidence-based assessments on the most effective treatments and authoritative clinical information on management of the conditions so you can confidently apply what you learn Physicians, surgeons, specialist nurses – any clinician seeking an accessible resource for designing and conducting cardiovascular trials and then translating their results into practice will appreciate this book’s clear guidance and succinct and practical approach.

Cardiovascular Disability

Cardiovascular Disability PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 030915698X
Category : Medical
Languages : en
Pages : 304

Get Book Here

Book Description
The Social Security Administration (SSA) uses a screening tool called the Listing of Impairments to identify claimants who are so severely impaired that they cannot work at all and thus immediately qualify for benefits. In this report, the IOM makes several recommendations for improving SSA's capacity to determine disability benefits more quickly and efficiently using the Listings.

Practical Considerations for Adaptive Trial Design and Implementation

Practical Considerations for Adaptive Trial Design and Implementation PDF Author: Weili He
Publisher: Springer
ISBN: 1493911007
Category : Medical
Languages : en
Pages : 420

Get Book Here

Book Description
This edited volume is a definitive text on adaptive clinical trial designs from creation and customization to utilization. As this book covers the full spectrum of topics involved in the adaptive designs arena, it will serve as a valuable reference for researchers working in industry, government and academia. The target audience is anyone involved in the planning and execution of clinical trials, in particular, statisticians, clinicians, pharmacometricians, clinical operation specialists, drug supply managers, and infrastructure providers. In spite of the increased efficiency of adaptive trials in saving costs and time, ultimately getting drugs to patients sooner, their adoption in clinical development is still relatively low. One of the chief reasons is the higher complexity of adaptive design trials as compared to traditional trials. Barriers to the use of clinical trials with adaptive features include the concerns about the integrity of study design and conduct, the risk of regulatory non-acceptance, the need for an advanced infrastructure for complex randomization and clinical supply scenarios, change management for process and behavior modifications, extensive resource requirements for the planning and design of adaptive trials and the potential to relegate key decision makings to outside entities. There have been limited publications that address these practical considerations and recommend best practices and solutions. This book fills this publication gap, providing guidance on practical considerations for adaptive trial design and implementation. The book comprises three parts: Part I focuses on practical considerations from a design perspective, whereas Part II delineates practical considerations related to the implementation of adaptive trials. Putting it all together, Part III presents four illustrative case studies ranging from description and discussion of specific adaptive trial design considerations to the logistic and regulatory issues faced in trial implementation. Bringing together the expertise of leading key opinion leaders from pharmaceutical industry, academia, and regulatory agencies, this book provides a balanced and comprehensive coverage of practical considerations for adaptive trial design and implementation.

Evidence-Based Cardiology

Evidence-Based Cardiology PDF Author: Christopher C. Cannon
Publisher: Lippincott Williams & Wilkins
ISBN: 1451148186
Category : Medical
Languages : en
Pages : 496

Get Book Here

Book Description
Thoroughly updated for its Third Edition, this pocket-sized handbook provides easy access to clinical trial data that are crucial in therapeutic decision-making. The book enables clinicians to quickly review the studies that support or refute an intervention and choose the most appropriate, cost-effective treatment. Each chapter summarizes the pathophysiology of a disease and guideline-recommended diagnostic tests and treatments, and presents synopses of the major clinical trials for all therapies. New sections in this Third Edition cover peripheral artery disease and drug-eluting stents. This edition also features expanded coverage of pacers and ICDs and an expanded section on preventive pre-hospital cardiology.

Evidence-based Cardiology

Evidence-based Cardiology PDF Author: Peter J. Sharis
Publisher: Lippincott Williams & Wilkins
ISBN: 9780781739108
Category : Medical
Languages : en
Pages : 390

Get Book Here

Book Description
Thoroughly updated with the most current clinical trials and the latest American College of Cardiology and American Heart Association guidelines, this pocket-sized handbook provides quick, easy access to clinical trial data that support or refute clinical interventions. Each chapter summarizes the pathophysiology of a disease and the guideline-recommended diagnostic tests and treatments, and presents synopses of the major clinical trials for all therapies. This edition includes a new preventive cardiology section, an index of trial acronyms, highlights of selected pivotal trials, and a new mini-section covering clinical reference formulas. This Second Edition is also available electronically for PDAs. See Media Products section for details.

Clinical Trials in Heart Disease

Clinical Trials in Heart Disease PDF Author: JoAnn E. Manson
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 456

Get Book Here

Book Description
This new edition covers important new trials in cardiology therapies and prevention of cardiovascular problems. The world authorities on pharmacologic clinical trials write about the trials, the outcomes and importance for clinical practice. This book gives the general cardiologist insight into the development of new therapies in cardiology as well as the process of how trials were used for those therapies. In addition to providing a manual for how to establish trials, trials for treatment and prevention are covered.

25 Landmark Trials in Cardiology

25 Landmark Trials in Cardiology PDF Author: Gabor Gyenes
Publisher: Lockeport, N.S. : Community Books 2006.
ISBN: 9781896496597
Category : Clinical trials
Languages : en
Pages : 61

Get Book Here

Book Description


Evidence-Based Cardiology

Evidence-Based Cardiology PDF Author: Salim Yusuf
Publisher: John Wiley & Sons
ISBN: 0470986875
Category : Medical
Languages : en
Pages : 1024

Get Book Here

Book Description
This second editionis a ground-breaking clinical text with a strong emphasis on rigorous evidence. Leaders in the field discuss best practice in the light of systematic reviews and randomised control trials, and how best to treat where the information is less clear. Case histories provide intriguing discussions on how to apply the evidence in real life situations. Evidence-based Cardiology also includes free access to the latest evidence, which is automatically posted on a companion website.

Key Trials of the Decade, An Issue of Interventional Cardiology Clinics, E-Book

Key Trials of the Decade, An Issue of Interventional Cardiology Clinics, E-Book PDF Author: Matthew J. Price
Publisher: Elsevier Health Sciences
ISBN: 0323776752
Category : Medical
Languages : en
Pages : 105

Get Book Here

Book Description
This issue of Interventional Cardiology Clinics, guest edited by Editor-in-Chief Matthew J. Price, will focus on Key Trials of the Decade. Trials discussed in this issue will include: Physiology over Angiography to determine lesion severity: The FAME trials; Percutaneous Coronary Intervention or surgery for multivessel disease: The SYNTAX trial at 10 years; Percutaneous Coronary Intervention or surgery for unprotected left main disease: The EXCEL trial at 5 years; Complete or Incomplete Revascularization for ST-Elevation Myocardial Infarction: the PRAMI trial and beyond; Abbreviated Dual Antiplatelet Therapy after PCI in High Bleeding Risk Patients: LEADERS-FREE and ONYX ONE; Transcatheter treatment of functional mitral regurgitation in patients with heart failure: The COAPT trial; Manual thrombectomy in Primary Percutaneous Coronary Intervention: Lessons learned from TOTAL; Paradigm shifts in the treatment of aortic stenosis: The PARTNER Trials experience; COURAGE and ORBITA in context: PCI for chronic stable CAD; SIMPLICITY to RADIANCE: Interpreting the past and mapping the future of renal denervation; From WOEST to AUGUSTUS: Dual Therapy after PCI; The ISCHEMIA Trial: Background, Design, Outcomes and Clinical Interpretation.